查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
植入式輸液泵市場 - 增長、未來前景、競爭分析，2023-2031 年
市場調查報告書
商品編碼
1313698

植入式輸液泵市場 - 增長、未來前景、競爭分析，2023-2031 年

Implantable Infusion Pumps Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

到2031 年，植入式輸液泵市場預計將增長5.2%。植入式輸液泵是一種小型設備，通過手術植入皮下，將藥物輸送到人體的特定區域，減輕疼痛。提供有針對性和持續的藥物治療為了緩解。 支持植入式輸液泵市場需求不斷增長的主要因素是老年人口的增加、慢性病的流行、醫療保健服務的普及以及私立醫院數量的增加。 健康意識的提高導致發達國家和發展中國家人口老齡化的增加，導致住院率上升和種植手術數量增加。 需要術後疼痛管理的慢性疾病的廣泛流行也可能對植入式輸液泵市場的增長產生積極影響。 醫療保險公司正在讓患病的患者更容易獲得更好的醫療服務。 私立醫院投入大量醫療和福利服務的增加以及向農村地區的擴張將對植入式輸液泵的市場滲透率產生積極影響。 然而，這種情況下的挑戰是藥物戒斷引起的潛在並發症、植入部位的疼痛和感染，以及與植入物相關的機械問題（齒輪失速、電池沒電），有可能導致嚴重傷害。 植入式輸液泵市場的製約因素包括報銷模糊、由於設備複雜性導致產品頻繁召回。 不明確的報銷政策是醫療保健領域支出的最大障礙，導致在需要藥物植入服務的疾病的費用覆蓋方面存在歧視。 複雜的泵設計和反復出現的藥物輸送故障導致頻繁的產品召回和巨大的產品研發成本。 這對植入式輸液泵的市場滲透率產生了負面影響。

胃腸道並發症、心血管疾病、糖尿病、癌症等主要慢性疾病在北美和歐洲呈上升趨勢，疾病認知度高，對微創手術的需求不斷增加，預計將推動植入式輸液器的增長該地區的泵市場。 然而，來自領先公司的激烈競爭需要在設計和應用方面實現突破性創新，以減少產品召回的可能性和對患者安全的不利影響。 亞太地區、中東和非洲是潛在市場，因為慢性病患病率高，需要立即進行醫療干預，但疾病意識較低。 可以開發偏遠和半城市地區未開發的市場。

Codman 和 Shurtleff (CODMAN 3000) 等製造商提供用於慢性疼痛治療的恆流藥物輸送。 美敦力 (Medtronics) 提供具有連續血糖監測功能的胰島素泵。 植入式輸液泵市場中觀察到的最新產品是滲透泵（ALZET）、球囊泵（Fresenius Kabi AG）。

目錄

第一章前言

  • 報告內容
    • 報告的目的
    • 目標受眾
    • 提供的主要產品
  • 市場細分
  • 調查方法
    • 第一階段-二次調查
    • 第二階段 - 初步調查
    • 第三階段-專家評審
    • 先決條件
    • 採用的方法

第 2 章執行摘要

第三章植入式輸液泵市場：競爭分析

  • 主要供應商的市場地位
  • 供應商採取的策略
  • 主要產業戰略
  • 層級分析：2022 年與 2031 年

第四章植入式輸液泵市場：宏觀分析和市場動態

  • 簡介
  • 2021-2031 年全球植入式輸液泵市場價值
  • 市場動態
    • 市場驅動因素
    • 市場製約因素
    • 主要挑戰
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

第 5 章植入式輸液泵市場：2021-2031 年副產品

  • 市場概覽
  • 增長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 患者自控鎮痛 (PCA) 泵
    • 腸內泵
    • 胰島素泵
    • 彈性體泵
    • 注射泵

第 6 章植入式輸液泵市場：按應用劃分 2021-2031

  • 市場概覽
  • 增長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 腫瘤學
    • 兒科/新生兒科
    • 胃腸病學
    • 血液學
    • 糖尿病

第 7 章植入式輸液泵市場：按最終用戶劃分，2021-2031 年

  • 市場概覽
  • 增長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 醫院
    • 門診手術中心
    • 診所
    • 家庭醫療護理

第8章北美植入式輸液泵市場2021-2031

  • 市場概覽
  • 植入式輸液泵市場：按產品分類 2021-2031
  • 植入式輸液泵市場：按應用劃分 2021-2031 年
  • 植入式輸液泵市場：按最終用戶劃分，2021-2031 年
  • 植入式輸液泵市場：按地區劃分，2021-2031 年
    • 北美
      • 美國
      • 加拿大
      • 其他北美地區

第 9 章英國和歐盟植入式輸液泵市場 2021-2031

  • 市場概覽
  • 植入式輸液泵市場：按產品分類 2021-2031
  • 植入式輸液泵市場：按應用劃分 2021-2031 年
  • 植入式輸液泵市場：按最終用戶劃分，2021-2031 年
  • 植入式輸液泵市場：按地區劃分，2021-2031 年
    • 英國和歐盟
      • 英國
      • 德國
      • 西班牙
      • 意大利
      • 法國
      • 其他歐洲地區

第 10 章亞太地區植入式輸液泵市場 2021-2031

  • 市場概覽
  • 植入式輸液泵市場：按產品分類 2021-2031
  • 植入式輸液泵市場：按應用劃分 2021-2031 年
  • 植入式輸液泵市場：按最終用戶劃分，2021-2031 年
  • 植入式輸液泵市場：按地區劃分，2021-2031 年
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區

第 11 章拉丁美洲植入式輸液泵市場 2021-2031

  • 市場概覽
  • 植入式輸液泵市場：按產品分類 2021-2031
  • 植入式輸液泵市場：按應用劃分 2021-2031 年
  • 植入式輸液泵市場：按最終用戶劃分，2021-2031 年
  • 植入式輸液泵市場：按地區劃分，2021-2031 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第十二章中東和非洲植入式輸液泵市場2021-2031

  • 市場概覽
  • 植入式輸液泵市場：按產品分類 2021-2031
  • 植入式輸液泵市場：按應用劃分 2021-2031 年
  • 植入式輸液泵市場：按最終用戶劃分，2021-2031 年
  • 植入式輸液泵市場：按地區劃分，2021-2031 年
    • 中東/非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東/非洲地區

第十三章公司簡介

  • Codman and Shurtleff
  • I-Flow Corp/Hylard Health
  • Flowobix Medical Inc.
  • Medtronic
  • Tricumed Medizintechnik GmbH.
  • B. Braun Melsungen AG.
  • CareFusion Corporation
  • Fresenius Kabi AG
  • Terumo Corporation
  • Baxter International Inc.
  • Smiths Medical
  • MOOG Inc.
  • Johnson & Johnson Private Ltd.
  • Hospira Inc.
  • Flowonix
  • he Tandem Diabetes Care
  • 其他主要公司
Product Code: 137228-06-23

Implantable infusion pumps market expected to Grow at 5.2% by 2031, Implantable infusion pumps are compact devices that are surgically implanted under the skin to deliver drug to specific parts of the human body, they provide targeted and consistent medication to reduce pain. The major factorial entities supporting the growth in demand for implantable infusion pumps market are rise in geriatric population, wide prevalence of chronic diseases, access to healthcare services and rise in private sector hospitals. Due to better health awareness there has been rise in geriatric population in both the developed and developing nations as a result the rate of hospitalization has increased the number of implant surgeries. Wide prevalence of chronic diseases requiring post-operative pain management will have a positive impact on the growth of the implantable infusion pumps market. Healthcare insurance companies have made it possible for ailing patients to access to better healthcare services. Rise in private sector hospitals spending huge amount on health and welfare and its expansion to rural areas have a positive impact on the deep market penetration of implantable infusion pumps. However, the challenges in this scenario would be drug withdrawal symptoms, pain and infection at the implant site and potential complications arising because of mechanical problems related to implant (gear stopping, battery dying) would lead to serious injury. Restraints regarding the implantable infusion pumps market are ambiguous reimbursement, frequent product recalls due to complexity of the equipment. Ambiguous reimbursement policies cause service discrimination in the cost coverage for the diseases requiring drug implant services which is the biggest hurdle for the expenditure in the healthcare domain. The complexity in the design of the pump and repetitive failure in the drug delivery of the pumps leading to frequent product recalls have led to huge expenditure on the product R&D. This has a negative impact on the market penetration of implantable infusion pumps market.

In North America and Europe there is an increasing number of major chronic diseases like gastrointestinal complications, cardiovascular diseases, diabetes and cancer, high disease awareness and rising demand for minimally invasive surgery is expected to assist the growth of implantable infusion pumps market in these regions. The pitfall being high degree of competition by major players which urges need for path breaking innovation in design and application to reduce the probability of product recalls and adverse impact on patient safety. Asia-Pacific and Middle East and Africa are potential market due to high prevalence of chronic diseases requiring immediate medical intervention but less disease awareness. The untapped market in the remote and semi-urban areas can be captured.

Manufacturers like Codman and Shurtleff (CODMAN 3000) provides constant flow of drug delivery for treatment of chronic pain. Medtronics provides insulin pumps with continuous glucose monitoring. The latest products observed in the implantable infusion pump market are Osmotic pumps (ALZET), Balloon pumps (Fresenius Kabi AG) are employed for better results.

Key players identified for global implantable infusion pumps market include:

Codman and Shurtleff, I-Flow Corp/Hylard Health, Flowobix Medical, Inc., Medtronic, Tricumed Medizintechnik GmbH., B. Braun Melsungen AG., CareFusion Corporation, Fresenius Kabi AG, Terumo Corporation, Baxter International Inc., Smiths Medical, MOOG Inc., Johnson & Johnson Private Ltd., and Hospira, Inc., Flowonix, The Tandem Diabetes Care And Other Notable Players.

This report offers:

  • An overview of the global implantable infusion pumps market.
  • Market trends assessment for the period 2015-2025, with historical information for 2015, and projections through 2025, with respective CAGRs during 2017-2025.
  • Qualitative assessment tools such as market drivers, challenges and future prospects.
  • Market competition scrutiny tools such as market share analysis, fractal map assessment.
  • Focus on each level of market segmentation based on product approvals, launch, and current and anticipated market dynamics.
  • A general overview of the industry structure.
  • Company profiles highlighting key information about the major players operating in the global implantable infusion pumps market.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofImplantable Infusion Pumps market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Implantable Infusion Pumps market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Patient-Controlled Analgesia (PCA) Pump
  • Enteral Pump
  • Insulin Pump
  • Elastomeric Pump
  • Syringe Pump

Application

  • Oncology
  • Pediatrics/Neonatology
  • Gastroenterology
  • Hematology
  • Diabetes

End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Clinics
  • Home Healthcare

Region Segment (2021-2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Implantable Infusion Pumps market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Implantable Infusion Pumps market?
  • Which is the largest regional market for Implantable Infusion Pumps market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Implantable Infusion Pumps market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Implantable Infusion Pumps market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Implantable Infusion Pumps Market
  • 2.2. Global Implantable Infusion Pumps Market, By Product, 2022 (US$ Million)
  • 2.3. Global Implantable Infusion Pumps Market, By Application, 2022 (US$ Million)
  • 2.4. Global Implantable Infusion Pumps Market, By End User, 2022 (US$ Million)
  • 2.5. Global Implantable Infusion Pumps Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Implantable Infusion Pumps Market: Competitive Analysis

  • 3.1. Market Positioning of Key Implantable Infusion Pumps Market Vendors
  • 3.2. Strategies Adopted by Implantable Infusion Pumps Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Implantable Infusion Pumps Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Implantable Infusion Pumps Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Patient-Controlled Analgesia (PCA) Pump
    • 5.3.2. Enteral Pump
    • 5.3.3. Insulin Pump
    • 5.3.4. Elastomeric Pump
    • 5.3.5. Syringe Pump

6. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Oncology
    • 6.3.2. Pediatrics/Neonatology
    • 6.3.3. Gastroenterology
    • 6.3.4. Hematology
    • 6.3.5. Diabetes

7. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centres
    • 7.3.3. Clinics
    • 7.3.4. Home Healthcare

8. North America Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 8.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 8.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 8.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

9. UK and European Union Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 9.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 9.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 9.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.4.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.5.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.6.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

10. Asia Pacific Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 10.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 10.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 10.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.4.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.5.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.6.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

11. Latin America Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 11.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 11.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 11.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

12. Middle East and Africa Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 12.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 12.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 12.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Codman and Shurtleff
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. I-Flow Corp/Hylard Health
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Flowobix Medical, Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Medtronic
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Tricumed Medizintechnik GmbH.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. B. Braun Melsungen AG.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. CareFusion Corporation
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Fresenius Kabi AG
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Terumo Corporation
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Baxter International Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Smiths Medical
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. MOOG Inc.
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives
  • 13.13. Johnson & Johnson Private Ltd.
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Portfolio
    • 13.13.4. Strategic Initiatives
  • 13.14. Hospira, Inc.
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Portfolio
    • 13.14.4. Strategic Initiatives
  • 13.15. Flowonix
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Portfolio
    • 13.15.4. Strategic Initiatives
  • 13.16. he Tandem Diabetes Care
    • 13.16.1. Company Overview
    • 13.16.2. Financial Performance
    • 13.16.3. Product Portfolio
    • 13.16.4. Strategic Initiatives
  • 13.17. Other Notable Players
    • 13.17.1. Company Overview
    • 13.17.2. Financial Performance
    • 13.17.3. Product Portfolio
    • 13.17.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 3 Global Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 4 North America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 5 North America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 6 North America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 7 U.S. Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 8 U.S. Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 9 U.S. Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 10 Canada Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 11 Canada Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 12 Canada Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 19 UK Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 20 UK Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 21 UK Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 22 Germany Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 23 Germany Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 24 Germany Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 25 Spain Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 26 Spain Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 27 Spain Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 28 Italy Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 29 Italy Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 30 Italy Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 31 France Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 32 France Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 33 France Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 37 Asia Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 38 Asia Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 39 Asia Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 40 China Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 41 China Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 42 China Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 43 Japan Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 44 Japan Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Japan Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 46 India Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 47 India Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 48 India Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 49 Australia Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Australia Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 51 Australia Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 52 South Korea Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 53 South Korea Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 54 South Korea Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 55 Latin America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 56 Latin America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 57 Latin America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 58 Brazil Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 59 Brazil Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 60 Brazil Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 61 Mexico Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 62 Mexico Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 63 Mexico Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 70 GCC Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 71 GCC Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 72 GCC Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 73 Africa Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Africa Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 75 Africa Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Implantable Infusion Pumps Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Implantable Infusion Pumps Market: Quality Assurance
  • FIG. 5 Global Implantable Infusion Pumps Market, By Product, 2022
  • FIG. 6 Global Implantable Infusion Pumps Market, By Application, 2022
  • FIG. 7 Global Implantable Infusion Pumps Market, By End User, 2022
  • FIG. 8 Global Implantable Infusion Pumps Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Implantable Infusion Pumps Market, 2022

FIG. 10Market Positioning of Key Implantable Infusion Pumps Market Players, 2022

FIG. 11Global Implantable Infusion Pumps Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 12 Global Implantable Infusion Pumps Market, By Product, 2022 Vs 2031, %
  • FIG. 13 Global Implantable Infusion Pumps Market, By Application, 2022 Vs 2031, %
  • FIG. 14 Global Implantable Infusion Pumps Market, By End User, 2022 Vs 2031, %
  • FIG. 15 U.S. Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 22 France Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 24 China Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 26 India Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Implantable Infusion Pumps Market (US$ Million), 2021 - 2031